Search results: Sage Journals

Restricted accessResearch articleFirst published May, 2026

Efficacy and Safety of Abrocitinib and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

Xinlin Huang, Mi Zhang, Sheng Wang [...]

Journal of Cutaneous Medicine and Surgery

Restricted accessReview articleFirst published January, 2023

Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis

Patrick O. Perche, Madison K. Cook, Steven R. Feldman

Annals of Pharmacotherapy

Open accessCase reportFirst published 2025

Treatment of Hailey-Hailey disease with the Janus kinase inhibitor abrocitinib: A case report

Molly Gunyon, Megha Udupa, Farhan Mahmood [...]

Sage Open Medical Case Reports

Open accessCase reportFirst published 2025

Recalcitrant vulvar lichen planus cleared on abrocitinib: A case report

Celina DeBiasio, Carly Kirshen

Sage Open Medical Case Reports

Open accessCase reportFirst published 2024

Rapid resolution of non-segmental vitiligo in a patient treated with abrocitinib: A case report

Seyyon Satkunanathan, Mina Boshra, Janis Chang [...]

Sage Open Medical Case Reports

Open accessCase reportFirst published May, 2024

Real-life experience of abrocitinib for the treatment of female patients with persistent erythema of rosacea

Yan Teng, Huiting Zhong, Youming Huang [...]

European Journal of Inflammation

Open accessCase reportFirst published 2025

Successful treatment of refractory erosive lichen planus with abrocitinib: A case report

Valerie Hladky, Deana Funaro, Rosalie-Sélène Meunier [...]

Sage Open Medical Case Reports

Open accessResearch articleFirst published June, 2026

Refractory nail lichen planus treated successfully with the Janus kinase 1 inhibitor abrocitinib: A case report

Liang Wang, Xia Lei, Lingfei Li [...]

Journal of International Medical Research

Open accessCase reportFirst published 2025

Refractory erythroderma in idiopathic hypereosinophilic syndrome: A case treated with mepolizumab and abrocitinib

Hiba Elhaj, Ahmad Al Amari, Fatemah Alyaqout [...]

Sage Open Medical Case Reports

Restricted accessResearch articleFirst published October, 2021

Rapid Improvement of Itch Associated with Atopic Dermatitis with Abrocitinib is Partially Independent of Overall Disease Improvement

Brian S. Kim, Jonathan I. Silverberg, Sonja Ständer [...]

Dermatitis®

Restricted accessResearch articleFirst published May, 2026

Efficacy and Safety of Abrocitinib and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

Xinlin Huang, Mi Zhang, Sheng Wang [...]

Journal of Cutaneous Medicine and Surgery

Restricted accessReview articleFirst published January, 2023

Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis

Patrick O. Perche, Madison K. Cook, Steven R. Feldman

Annals of Pharmacotherapy

Open accessCase reportFirst published 2025

Treatment of Hailey-Hailey disease with the Janus kinase inhibitor abrocitinib: A case report

Molly Gunyon, Megha Udupa, Farhan Mahmood [...]

Sage Open Medical Case Reports

Open accessCase reportFirst published 2025

Recalcitrant vulvar lichen planus cleared on abrocitinib: A case report

Celina DeBiasio, Carly Kirshen

Sage Open Medical Case Reports

Open accessCase reportFirst published 2024

Rapid resolution of non-segmental vitiligo in a patient treated with abrocitinib: A case report

Seyyon Satkunanathan, Mina Boshra, Janis Chang [...]

Sage Open Medical Case Reports

Open accessCase reportFirst published May, 2024

Real-life experience of abrocitinib for the treatment of female patients with persistent erythema of rosacea

Yan Teng, Huiting Zhong, Youming Huang [...]

European Journal of Inflammation

Open accessCase reportFirst published 2025

Successful treatment of refractory erosive lichen planus with abrocitinib: A case report

Valerie Hladky, Deana Funaro, Rosalie-Sélène Meunier [...]

Sage Open Medical Case Reports

Open accessResearch articleFirst published June, 2026

Refractory nail lichen planus treated successfully with the Janus kinase 1 inhibitor abrocitinib: A case report

Liang Wang, Xia Lei, Lingfei Li [...]

Journal of International Medical Research

Open accessCase reportFirst published 2025

Refractory erythroderma in idiopathic hypereosinophilic syndrome: A case treated with mepolizumab and abrocitinib

Hiba Elhaj, Ahmad Al Amari, Fatemah Alyaqout [...]

Sage Open Medical Case Reports

Restricted accessResearch articleFirst published October, 2021

Rapid Improvement of Itch Associated with Atopic Dermatitis with Abrocitinib is Partially Independent of Overall Disease Improvement

Brian S. Kim, Jonathan I. Silverberg, Sonja Ständer [...]

Dermatitis®